TG Therapeutics Inc (TGTX)
14.21
-0.04
(-0.28%)
USD |
NASDAQ |
Apr 24, 09:56
TG Therapeutics Profit Margin (Quarterly): -32.79% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.79% |
| September 30, 2023 | 68.71% |
| June 30, 2023 | -296.2% |
| March 31, 2023 | -502.8% |
| December 31, 2022 | -66.24K% |
| September 30, 2022 | -38.10K% |
| June 30, 2022 | -6.82K% |
| March 31, 2022 | -3.42K% |
| December 31, 2021 | -4.02K% |
| September 30, 2021 | -4.22K% |
| June 30, 2021 | -5.08K% |
| March 31, 2021 | -11.43K% |
| December 31, 2020 | -232.2K% |
| September 30, 2020 | -229.4K% |
| June 30, 2020 | -139.2K% |
| March 31, 2020 | -134.5K% |
| December 31, 2019 | -104.1K% |
| September 30, 2019 | -163.0K% |
| June 30, 2019 | -95.30K% |
| March 31, 2019 | -92.52K% |
| December 31, 2018 | -141.7K% |
| September 30, 2018 | -89.34K% |
| June 30, 2018 | -116.2K% |
| March 31, 2018 | -109.3K% |
| December 31, 2017 | -81.21K% |
| Date | Value |
|---|---|
| September 30, 2017 | -82.99K% |
| June 30, 2017 | -74.61K% |
| March 31, 2017 | -72.97K% |
| December 31, 2016 | -62.77K% |
| September 30, 2016 | -65.18K% |
| June 30, 2016 | -41.74K% |
| March 31, 2016 | -36.35K% |
| December 31, 2015 | -46.23K% |
| September 30, 2015 | -35.85K% |
| June 30, 2015 | -44.90K% |
| March 31, 2015 | -38.27K% |
| December 31, 2014 | -49.34K% |
| September 30, 2014 | -45.81K% |
| June 30, 2014 | -31.46K% |
| March 31, 2014 | -19.81K% |
| December 31, 2013 | -14.87K% |
| September 30, 2013 | -11.96K% |
| June 30, 2013 | -17.28K% |
| March 31, 2013 | -9.64K% |
| December 31, 2012 | -18.16K% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-232.2K%
Minimum
Dec 2020
68.71%
Maximum
Sep 2023
-65.14K%
Average
-11.43K%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -29.41% |
| Geron Corp | -226.0K% |
| Editas Medicine Inc | -31.43% |
| G1 Therapeutics Inc | -73.14% |
| Mersana Therapeutics Inc | -182.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.03% |
| Return on Assets | 4.98% |
| Return on Invested Capital | 7.75% |
| Gross Profit Margin (Quarterly) | 82.14% |
| Operating Margin (Quarterly) | -28.39% |
| Return on Net Operating Assets | 19.99% |